Patent details

Basic Information

Publication number:

EP2343282

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101796183

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Diaminopyrimidines as P2X3 and P2X2/3 antagonists

French Title of Invention:

Diaminopyrimidines en tant qu'antagonistes P2X3 et P2X2/3

German Title of Invention:

Diaminpyrimidine als P2X3- und P2X2/3-Antagonisten

SPC Number:

Dates

Filing date:

25/02/2005

Grant date:

22/07/2015

EP Publication Date:

22/07/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/07/2011

EP B1 Publication Date:

22/07/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/02/2016

Expiration date:

25/02/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/02/2005

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

Parish Daniel Warren

Address:

United States (US)

2

Name:

Jahangir Alam

Address:

United States (US)

3

Name:

Lin Clara Jeou Jen

Address:

United States (US)

4

Name:

Dillon Michael Patrick

Address:

United States (US)

5

Name:

Carter David Scott

Address:

United States (US)

6

Name:

Broka Chris Allen

Address:

United States (US)

7

Name:

Hawley Ronald Charles

Address:

United States (US)

Priority

Priority Number:

550499 P

Priority Date:

05/03/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 239/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages